Skip to main content
Fig. 7 | Journal of Translational Medicine

Fig. 7

From: GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experiments

Fig. 7

The effects of mTOR inhibitor-GSK2126458 on pancreatic cancer cells. A MTT result of GSK216458 on PANC1 cell. B MTT result of GSK216458 on BxPC-3 cell. C Colony formation invasion results of GSK216458 on PANC1 cell. D FACS result of GSK216458 on PANC1 cell. E Statistical histogram of FACS results. F The mRNA expression of COL3A1, EGF, FN1 and ITGA2. The data came from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, compared with the control group

Back to article page